Biofarm S.A. (BVB:BIO)

Biofarm Statistics

Total Valuation

Biofarm has a market cap or net worth of RON 788.29 million. The enterprise value is 603.55 million.

Market Cap	788.29M
Enterprise Value	603.55M

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	Aug 18, 2025

Share Statistics

Biofarm has 985.37 million shares outstanding.

Current Share Class	985.37M
Shares Outstanding	985.37M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	88.43%
Float	476.14M

Valuation Ratios

The trailing PE ratio is 8.94.

PE Ratio	8.94
Forward PE	n/a
PS Ratio	2.47
PB Ratio	1.47
P/TBV Ratio	1.48
P/FCF Ratio	8.77
P/OCF Ratio	7.58
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.47, with an EV/FCF ratio of 6.71.

EV / Earnings	6.84
EV / Sales	1.89
EV / EBITDA	5.47
EV / EBIT	6.49
EV / FCF	6.71

Financial Position

The company has a current ratio of 4.94, with a Debt / Equity ratio of 0.00.

Current Ratio	4.94
Quick Ratio	4.41
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	0.01
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 17.43% and return on invested capital (ROIC) is 11.47%.

Return on Equity (ROE)	17.43%
Return on Assets (ROA)	10.00%
Return on Invested Capital (ROIC)	11.47%
Return on Capital Employed (ROCE)	17.35%
Revenue Per Employee	874,440
Profits Per Employee	241,661
Employee Count	373
Asset Turnover	0.55
Inventory Turnover	1.13

Taxes

In the past 12 months, Biofarm has paid 12.68 million in taxes.

Income Tax	12.68M
Effective Tax Rate	12.57%

Stock Price Statistics

The stock price has increased by +5.82% in the last 52 weeks. The beta is 0.27, so Biofarm's price volatility has been lower than the market average.

Beta (5Y)	0.27
52-Week Price Change	+5.82%
50-Day Moving Average	0.81
200-Day Moving Average	0.77
Relative Strength Index (RSI)	44.84
Average Volume (20 Days)	63,798

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biofarm had revenue of RON 319.17 million and earned 88.21 million in profits.

Revenue	319.17M
Gross Profit	268.34M
Operating Income	93.03M
Pretax Income	100.89M
Net Income	88.21M
EBITDA	110.39M
EBIT	93.03M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 185.76 million in cash and 1.01 million in debt, giving a net cash position of 184.75 million or 0.19 per share.

Cash & Cash Equivalents	185.76M
Total Debt	1.01M
Net Cash	184.75M
Net Cash Per Share	0.19
Equity (Book Value)	534.78M
Book Value Per Share	n/a
Working Capital	313.33M

Cash Flow

In the last 12 months, operating cash flow was 103.98 million and capital expenditures -14.09 million, giving a free cash flow of 89.88 million.

Operating Cash Flow	103.98M
Capital Expenditures	-14.09M
Free Cash Flow	89.88M
FCF Per Share	0.09

Margins

Gross margin is 84.07%, with operating and profit margins of 29.15% and 27.64%.

Gross Margin	84.07%
Operating Margin	29.15%
Pretax Margin	31.61%
Profit Margin	27.64%
EBITDA Margin	34.59%
EBIT Margin	29.15%
FCF Margin	28.16%

Dividends & Yields

This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 3.88%.

Dividend Per Share	0.03
Dividend Yield	3.88%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	3
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	3.83%
Earnings Yield	11.19%
FCF Yield	11.40%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 30, 2008. It was a forward split with a ratio of 1.12001.

Last Split Date	Apr 30, 2008
Split Type	Forward
Split Ratio	1.12001

Scores

Altman Z-Score	n/a
Piotroski F-Score	5